Can We Improve the Quality of Care at the End of Life in Israel?

NCT02129283 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-05-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether end-of-life training of ICU professionals leads to improvements in ICU care process, teamwork and family satisfaction.

Conditions

  • End of Life Process

Interventions

BEHAVIORAL

Simulation training

End-of-life simulation training. The simulation training will include training with standardized patients (actors) using 9 essential skills for communication and interpersonal relationships. The control group will have no training.

Sponsors & Collaborators

  • Israel Center for Medical Simulation (MSR)

    collaborator UNKNOWN
  • Clalit Health Services

    collaborator OTHER
  • The Samuel Sebba Charitable Trust

    collaborator UNKNOWN
  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Charles L Sprung, MD · Hadassah Medical Organization

  • Amiram Lev, MD · Afula Hospital, Afula, Israel

  • Moti Klein, MD · Soroka Hospital, Beer Sheva

  • Nimrod Adi · Kaplan Hospital, Rechovot, Israel

  • Pierre Singer, MD · Beilinson Hospital, Petach Tikva,Israel

  • Arik Eden, MD · Carmel Hospital, Haifa, Israel

  • Nissim Yifrach, MD · Meir Hospital, Kfar Saba, Israel

  • Shaul Lev, MD · Sharon Hospital, Herzilia, Israel

  • Amitai Ziv, MD · Israel Center for Medical Simulation (MSR), The Sheba Medical Center, Tel Hashomer , Ramat Gan, Israel

  • Yigal Shoshan, MD · Hadassah Medical Organization

  • Mayer Brezis, MD · Hadassah Medical Organization

  • Eyal Jacobson, MD · Ministry of Health, Israel

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2017-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129283 on ClinicalTrials.gov